Safety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult Subjects
NCT04416126
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Ornithine Transcarbamylase Deficiency
Interventions
BIOLOGICAL:
ARCT-810
OTHER:
Placebo
Sponsor
Arcturus Therapeutics, Inc.